T0	Interventions 19 45	gemcitabine plus docetaxel
T1	Interventions 53 80	capecitabine plus docetaxel
T2	Interventions 198 229	gemcitabine plus docetaxel (GD)
T3	Interventions 234 266	capecitabine plus docetaxel (CD)
T4	Interventions 354 380	monotherapy (GD→C or CD→G)
T5	Interventions 473 491	either gemcitabine
T6	Interventions 521 535	plus docetaxel
T7	Interventions 554 571	1 or capecitabine
T8	Interventions 605 624	1-14 plus docetaxel
T9	Interventions 670 700	received crossover monotherapy
T10	Interventions 1077 1081	More
T11	Interventions 1124 1128	than
T12	Interventions 1330 1339	comparing
T13	Interventions 1343 1346	and
T14	Interventions 1528 1535	groups.
T15	Interventions 1629 1641	neutropenia;
T16	Interventions 1719 1730	CONCLUSIONS
T17	Interventions 1734 1737	and